ARCHIVES

FASEB Urges Better Funding, Management Of Biomedical Research

This article is from The Cancer Letter archive.

Vol. 22 No. 08 | February 23, 1996

Download PDF Visit The Full Archive

Related Articles

AGS-003 Immunotherapy Induces T Cell Responses in Phase II Trial

November 29, 2013

ASCO Hit On Two Sides; AACR Split Criticized

June 26, 1992

Shift Of $6.5 Million From Contracts to Pay Core, P01s At Recommended Levels, Increase R01 Payline

June 27, 1980

LDK378 Demonstrates 58 Percent Overall Response Rate in Phase I

April 25, 2014

With $1.1 Billion At Stake, Cancer Groups Mull Comparative Effectiveness Studies

May 22, 2009

In Brief: Surgeons Oncology Group Gets NCI Funding To Conduct Multicenter Clinical Trials

April 17, 1998